Interim recommendations for use of the Moderna mRNA-1273 vaccine against COVID-19

Interim guidance

Overview

This interim guidance has been developed on the basis of the advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) at its extraordinary meeting on 21 January 2021.

 

WHO Team
COVAX, WHO Headquarters (HQ)
Editors
World Health Organization
Number of pages
8
Reference numbers
WHO Reference Number: WHO/2019-nCoV/vaccines/SAGE_recommendation/mRNA-1273/2021.1
Copyright
CC BY-NC-SA 3.0 IGO